Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis.

BACKGROUND The effect of intensive therapy to achieve tight glycemic control in patients hospitalized in non-critical care settings is unclear. METHODS We conducted a systematic review and meta-analysis to determine the effect of intensive glycemic control strategies on the outcomes of death, stroke, myocardial infarction, incidence of infection, and hypoglycemia. We included randomized and observational studies. Bibliographic databases were searched through February 2010. Random effects model was used to pool results across studies. RESULTS Nineteen studies (nine randomized and 10 observational studies) were included. The risk of bias across studies was moderate. Meta-analysis demonstrates that intensive glycemic control was not associated with significant effect on the risk of death, myocardial infarction, or stroke. There was a trend for increased risk of hypoglycemia (relative risk, 1.58; 95% confidence interval, 0.97-2.57), particularly in surgical studies and when the planned glycemic target was achieved. Intensive glycemic control was associated with decreased risk of infection (relative risk, 0.41; 95% confidence interval, 0.21-0.77) that was mainly derived from studies in surgical settings. CONCLUSION Intensive control of hyperglycemia in patients hospitalized in non-critical care settings may reduce the risk of infection. The quality of evidence is low and mainly driven by studies in surgical settings.

[1]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[2]  Limin Peng,et al.  Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.

[3]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[4]  W. Hueston,et al.  Glycemic Control in Medical Inpatients with Type 2 Diabetes Mellitus Receiving Sliding Scale Insulin Regimens versus Routine Diabetes Medications: A Multicenter Randomized Controlled Trial , 2003, The Annals of Family Medicine.

[5]  L. Mandarino,et al.  Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.

[6]  R. Mcnutt,et al.  Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. , 2005, Diabetes care.

[7]  R. Clements,et al.  Rapid insulin initiation in non-insulin-dependent diabetes mellitus. , 1987, The American journal of medicine.

[8]  M. Mclean,et al.  The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. , 2006, Diabetes care.

[9]  D. Kansagara,et al.  Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review , 2011, Annals of Internal Medicine.

[10]  Xiangtong Zhang,et al.  Intensive insulin therapy on infection rate, days in NICU, in-hospital mortality and neurological outcome in severe traumatic brain injury patients: a randomized controlled trial. , 2009, International journal of nursing studies.

[11]  Gordon H Guyatt,et al.  Patient-important outcomes in registered diabetes trials. , 2008, JAMA.

[12]  Richard Hellman,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  F. Brancati,et al.  Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. , 1999, Diabetes care.

[14]  H. Krumholz,et al.  Glucose normalization and outcomes in patients with acute myocardial infarction. , 2009, Archives of internal medicine.

[15]  Diane Marshall,et al.  Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery. , 2008, Journal of diabetes and its complications.

[16]  L. Kennedy,et al.  Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) , 2008 .

[17]  K.-A. Lee,et al.  Sliding Scale Versus Tight Glycemic Control in the Noncritically III at a Community Hospital , 2009, The Annals of pharmacotherapy.

[18]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[19]  Felix Zijlstra,et al.  Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. , 2003, Journal of the American College of Cardiology.

[20]  E. Jéquier,et al.  Effects of glucocorticoids and sympathomimetic agents on basal and insulin-stimulated glucose metabolism. , 1995, Clinical physiology.

[21]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .

[22]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[23]  I. Olkin,et al.  The case of the misleading funnel plot , 2006, BMJ : British Medical Journal.

[24]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[25]  B. Glaser,et al.  In-hospital treatment of hyperglycemia: effects of intensified subcutaneous insulin treatment , 2007, Current medical research and opinion.

[26]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[27]  M. Renvall,et al.  Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. , 2009, Journal of hospital medicine.

[28]  G. Guyatt,et al.  A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. , 2008, The Journal of clinical endocrinology and metabolism.

[29]  G. Angelini,et al.  Inadequate Blood Glucose Control Is Associated With In-Hospital Mortality and Morbidity in Diabetic and Nondiabetic Patients Undergoing Cardiac Surgery , 2008, Circulation.

[30]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[31]  R. Eaton,et al.  The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic man. , 1980, The Journal of clinical endocrinology and metabolism.

[32]  V. Pettilä,et al.  Strict versus moderate glucose control after resuscitation from ventricular fibrillation , 2007, Intensive Care Medicine.

[33]  Limin Peng,et al.  Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.

[34]  J Herlitz,et al.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.

[35]  I. Hirsch,et al.  New insulin infusion protocol Improves blood glucose control in hospitalized patients without increasing hypoglycemia. , 2005, Joint Commission journal on quality and patient safety.

[36]  G. Umpierrez,et al.  Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery , 2010, Diabetes Care.

[37]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[38]  M. Walters,et al.  A Randomised, Controlled Pilot Study to Investigate the Potential Benefit of Intervention with Insulin in Hyperglycaemic Acute Ischaemic Stroke Patients , 2006, Cerebrovascular Diseases.

[39]  J. Pomposelli,et al.  Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. , 1998, JPEN. Journal of parenteral and enteral nutrition.

[40]  M. Laakso,et al.  Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity , 2005 .